Pathology of The Breast

Slides:



Advertisements
Similar presentations
Breast Pathology Helge Stalsberg MD University Hospital of North Norway.
Advertisements

Histopathology and staging of breast cancer
A program of the UAMS College of Pharmacy
Breast Cancer 101 Barbara Lee Bass, MD, FACS Professor of Surgery
Breast Pathology Dr. M. Griffin.
Breast.
Breast Imaging Made Brief and Simple
Breast Cancer Presentation by Dr Mafunga. Breast cancer in the UK Breast cancer is the second most common cancer in women. Around 1 in 9 women will develop.
Thyroid nodules and neoplasms EMAD RADDAOUI, MD, FCAP, FASC ASSOCIATE PROFESSOR; CONSULTANT HISTOPATHOLOGY & CYTOPATHOLOGY.
BREAST CANCER.
ASSESSMENT OF BREAST SYMPTOMS/LUMPS Professor P Grantley Gill Specialists Without Borders Seminar in Surgery Rwanda, September 2010.
Morphology of breast cancer
Case Study 63: Cancer of the Female Breast
BREAST CANCER GROUP 6 :  Nuraini Ikqtiarzune Haryono( )  Tri Wahyu Ningsih ( )  Rani Yuswandaru ( )  Anita Rheza Fitriana Putri( )
Breast disease Dr. A. Basu MD.
Breast Cancer Katrina Allen Shanice Willies. What is Breast Cancer? Maligment tumor in breast Starts in lining of ducts.
Terminology of Neoplasms and Tumors  Neoplasm - new growth  Tumor - swelling or neoplasm  Leukemia - malignant disease of bone marrow  Hematoma -
Breast Carcinoma. Anatomy Epidemiology: 10% 17.1/10 28/10 46/ m world wide 6% develop cancer of the breast in their lifetime. 50,000 to 70,000.
First month Second Month First month Second Month Milk line remnant Milk line remnant Accessory axillary breast tissue Accessory axillary breast tissue.
CANCER BREAST OVERVIEW Dr. Ehab M.Oraby. INTRODUCTION  Breast is a modified sweat gland between skin and pectoral fascia.
Pathology of The Breast- 1
Ch 35 BREAST CANCER 부산백병원 산부인과 R1 서 영 진 R1 서 영 진.
 General recommendations -adjuvant systemic therapy :with tamoxifen or multiple-chemotherapy agent :lower the incidence of recurrence by about 30% - in.
Elsevier items and derived items © 2006 by Elsevier Inc. Assessment and Management of Patients With Breast Disorders.
Breast cancer -most common -Second common ( Death ) new case ( 2003 ) diagnosed - Lifetime Risk 2.5 % ( 1-8 )
Breast Cancer Breast Cancer DR/FATMA AL-THOUBAITY ASSOCIATE PROFESSOR SURGICAL CONSULTANT.
Breast Pathology Emad Raddaoui, MD, FCAP, FASC
IN THE NAME OF GOD BREAST DISEASE E.Naghshineh M.D.
Breast Cancer By: Christen Scott.
Female Genital Tract Lab Dr. Nisreen Abu Shahin Assistant Professor of Pathology University of Jordan.
Manzano, Clairol  Marcelo, Pamela Marcial, Karmi Margaret  Matematico, Michelle Matias, Evangelyn  Maulion, Marienelle.
BREAST CANCER: Half a million women later… Amy Miglani M.D September 3, 2004.
BREAST Begashaw M (MD). Introduction Modified sweat gland - produces milk Breast ca - most common cause of death Benign conditions  discomfort  confusion.
Breast Cancer. Breast cancer is a disease in which malignant cells form in the tissues of the breast – “National Breast Cancer Foundation” The American.
Interventions for Clients with Lung Cancer
Breast. Differential diagnosis for breast lump Malignant lump Breast abscess Fibrocystic changes: Lumpiness, thickening and swelling, often associated.
Vol 1. Cancer in general Cancer is a term used for diseases in which abnormal cells divide without control and are able to invade other tissues. Cancer.
Pathology.
Breast Cancer Dr. Gehan Mohamed. Introduction Most common female cancer. The incidence of breast cancer increases with age. 80% of cases occur in post-menopausal.
Breast Cancer »Breast cancer is a malignant tumor that starts in the cells of the breast. »The disease occurs almost entirely in women,but men can get.
Breast Cancer 1. Leukemia & Lymphoma New diagnoses each year in the US: 112, 610 Adults 5,720 Children 43,340 died of leukemia or lymphoma in
By: Anthony, Sophia, Jessica, Terrance, and Sierra.
Lesions of female breast are much more common than lesions of male breast Most of these lesions are benign Breast cancer is 2 nd most common cause of.
Female Reproductive System Kristine Krafts, M.D..
The Elliott Breast Center * Baton Rouge, LA *
What is Breast Cancer ? Abnormal cells develop from normal cells in the breast to form tumors Abnormal cells develop from normal cells in the breast to.
SURGICAL ONCOLOGY AND TUMOR MARKERS
Supported by Ronning Against Cancer,
Assessment and Management of Patients With Breast Disorders
Breast Cancer Protocol
Dr.Nik Makretsov, MD, PhD, FRCPC
Breast Cancer: The number speaks
Case scenario- Breast Lump
BREAST CANCER Walid Galal El Shazly
Chapter 3 Neoplasms 1.
الجامعة السورية الخاصة كلية الطب البشري قسم الجـراحـة
Case scenario- Breast Lump
Male and Female Reproductive Health Concerns
Breast Cancer Awareness and Prevention
CLINICAL BREAST EXAMINATION
Dr. Sura Obay Al-Dewachi
Breast Health Katherine B. Lee, MD, FACP April 26, 2018.
Uterine cancer Uterine mesenchymal neoplasms
Diseases of the breast (2 of 2)…Breast cancer
Handling and Evaluation of Breast Cancer Biopsy
Marion C.W. Henry, MD Yale University
Principles and Practice of Radiation Therapy
Presentation transcript:

Pathology of The Breast Anything added is italic

Most of these lesions are benign Lesions of female breast are much more common than lesions of male breast Most of these lesions are benign Breast cancer is 1st most common cancer; and 2nd most common cause of cancer deaths in women, following carcinoma of the lung. Benign conditions are more common than malignancy (look next slide) clinical significance of benign conditions: 1- possible clinical confusion with malignancy 2- association of certain variants with breast carcinoma. MORE COMMON IN FEMALES

Breast diseases (patients with symptoms in breast) Symptoms are an exaggeration of normal physiology Bnign tumor of the breast

Major symptoms involving the breast سلايد مضاف added slide Major symptoms involving the breast Breast lump Pain and tenderness Nipple discharge As we already said, underlying cause more commonly is a benign condition. But still, they might indicate carcinoma.

Fibrocystic changes Fibro: Fibrosis, cystic: cyst formation, changes: a spectrum of changes in breast tissue responding to cyclic hormonal changes rather than a disease) most common cause of breast "lumps” exaggeration of cyclic breast changes that occur normally in the menstrual cycle. HRT and OCPs do not increase incidence; (OCPs may decrease the risk). arise during reproductive period of life and regress following menopause (because it’s dependent on hormones Very common (at autopsy 60%-80% of women). Could be asymptomatic A spectrum of changes (fibrosis and cysts formation in one side, to proliferative types)

سلايد مضاف added slide Cyclic changes in breast Follicular/ Proliferative phase Luteal / secretory under the effect of estrogen Proliferation of cells in breast substance Under the effect of progesterone Producrion of Secretions in breast substance Breast histology: Lobules: secrete Ductules:to distal ductal system that open into the nipple Fibrocystic changes involve both lobules and ductules Spectrum.. Fibrosis and cyst formation Proliferative + Atypia (atypical hyperplasia) Increased risk of carcinoma in either breast

TUMORS OF THE BREAST

1- Fibroadenoma (biphasic growth involves fibrous tissue (fibro) and glands (adeno). oma=benign  most common benign neoplasm of female breast. Usually young age increase in estrogen activity enlarge late in menstrual cycle and during pregnancy. After menopause regress and calcify. Most in third decade of life. a discrete, solitary, freely movable nodule, (1 to 10 cm). Usually easily "shelled out“ surgically. i.e. during physical examination the lesion is not fixed to the overlying skin or underlying chest wallMeans that it hasn’t invaded surrounding tissue

Fibroadenoma Stromal cells are the source of neoplasm Cytogenetic studies  stromal cells are monoclonal and so represent the neoplastic element of these tumors (the neoplastic stromal cells secrete growth factors that induce proliferation of epithelial cells(the glands)). Fibroadenomas almost never become malignant.

Fibroadenoma Well-demarcated Stroma Gland (lobules and ductules)

Carcinoma of the Breast   the most common cancer in females ranking second only to lung cancer as a cause of cancer death in women. 75% are older than age 50. Only 5% are < 40.(familial cases)

Pathogenesis (1)Genetic Changes familial syndromes (BRCA genes) BRCA genes are also involvedd in familial serous ovarian cancers and cancers in fallopian tubes sporadic breast cancer: e.g. overexpression of the HER2/NEU proto-oncogene( an epithelial growth factor receptor) (30% of cases) (2)Hormonal Influences increased exposure to estrogen (unopposed estrogen: high levels of estrogen are not balanced by progesterone) (3)Environmental Variables

Don’t memorize this table just know the circled things and the side notes. Factor Relative Risk Well-Established Influences   Geographic factors Varies in different areas Age Increases after age 30yr Family history   First-degree relative with breast cancer 1.2-3.0   Premenopausal 3.1   Premenopausal and bilateral 8.5-9.0   Postmenopausal 1.5   Postmenopausal and bilateral 4.0-5.4 Menstrual history   Age at menarche <12yr 1.3   Age at menopause >55yr 1.5-2.0 Pregnancy   First live birth from ages 25 to 29yr   First live birth after age 30yr 1.9   First live birth after age 35yr 2.0-3.0   Nulliparous 3.0 Benign breast disease   Proliferative disease without atypia 1.6   Proliferative disease with atypical hyperplasia >2.0   Lobular carcinoma in situ 6.9-12.0 Less Well-Established Influences Exogenous estrogens Oral contraceptives Obesity High-fat diet Alcohol consumption Cigarette smoking Low level of evidence

From the previously presented table: سلايد مضاف added slide From the previously presented table: Risk factors of breast cancer: Age Family history; only worrisome if: - it is a 1st degree relative (mother, sister, or daughter) -she got it before the age of 45 -it was bilateral (indicates a field defect + it might be lobular carcinoma which is bilateral and could be familial) -she was premenopausal Menestural history ( early menerache and late menopause increase your risk because that mean you were exposed to estrogen for longer periods Pregnancy is protective (it increases progesterone levels) . Null parity (ما خلفت) and increased age at first delivery increase your risk Benign neoplasms: if proliferative fibrocystic changes + atypia  Carcinoma in situ

Major Risk Factors Age. Genetics and Family History: 50% of hereditary breast cancer  mutations in BRCA1; 30% in BRCA2 . Prolonged exposure to exogenous estrogens postmenopausally (hormone replacement therapy HRT) Ionizing radiation, in early life years

Morphology of breast cancer - The locations of the tumors within breast are: Upper outer quadrant 50% (most common) Most of the breast substance (lobules and associated ductules) is in that area Central portion (sub-areola) 20% Lower outer quadrant 10% Upper inner quadrant 10% Lower inner quadrant 10%

Will be discussed today Breast cancers are classified into: Noninvasive (Carcinoma in situ)(confined by a basement membrane and do not invade into stroma or lymphovascular channels) , include: Ductal carcinoma in situ (DCIS) . Most common Lobular carcinoma in situ (LCIS). Confined by BM of the lobule Invasive (infiltrating) Invasive ductal carcinoma – also called: NOS (not otherwise specified يعني: ليس أيًا من الأنواع الأخرى) (most common type (70-80% of cases), and worst type) Invasive lobular carcinoma (nearly 20% of cases) Medullary carcinoma Colloid (mucinous) carcinoma Tubular carcinoma Other types Will be discussed today

Malignant breast carcinoma: you can see infiltrative borders of the tumor indicate malignancy

Ductal carcinoma in-situ DCIS ranges from low to high nuclear grade. comedo subtype of DCIS: high-grade nuclei with extensive central necrosis. (The name derives from the toothpaste-like necrotic tissue). Calcifications are common screening by mammography. If micocalcifications wrer detected in mammogramy they should be biopsied Prognosis : excellent (97% survival post mastectomy) and yes, they undergo mastectomy Treatment strategies: surgery, radiation, tamoxifen (antiestrogen) Significance: adjacent invasive CA; become invasive if untreated Ducts become filled with dysplastic cells , they become distended and large in size and centrally cells become necrotic giving the appearance of tooth paste- like material Extra: Remember from general pathology that dystrophic calcificstion happens on top of necrosis

Comedo DCIS Necrosis

Invasive ductal carcinoma "not otherwise specified“= NOS 70% to 80% Precancerous lesion: DCIS Clinical presentation: a mammographic density; a hard palpable mass. Advanced cancers may cause retraction of nipple, or fixation to chest wall. Receptor profile (important prognostically and therapeutically i.e. targeted therapy): 2/3 express Estrogen Receptor (use tamoxifen) or Progesterone Receptor; 1/3 overexpresses HER2/NEU.(use antiboy against HER2/NEU called herceptin)

Invasive ductal carcinoma

Invasive lobular carcinoma < 20% of all breast carcinomas. Precancerous lesion. LCIS (2/3) . multicentric and bilateral (10% to 20%). If you find in one breast you should check the other Lots of cases are familial so if a patient was diagnosed other first degree family members are recommended to be evaluated Clinical presentation. palpable masses or mammographic densities Almost all of these carcinomas express ER and PR, but HER2/NEU overexpression is usually absent.

Physical Features Common to All Invasive Cancers Might be discovered by the patient or examiner Fixation: tumor adherence to pectoral muscles or deep fascia of chest wall retraction or dimpling of skin or nipple: tumor adherence to overlying skin peau d'orange (orange peel): Involvement of lymphatic pathways cause localized lymphedema; the skin becomes thickened around exaggerated hair follicles A type of localized edema involving the breast when Lymphatic channels are occluded by tumor

Spread of Breast Cancer Carcinoma usu favors lymphatic spread But sometimes hematogenous spread is involved as well Spread of Breast Cancer lymphatic and hematogenous channels. Favored mets are the lungs, skeleton, liver, and adrenals and (less commonly) the brain, spleen, and pituitary. Metastases may appear many years after apparent therapeutic control of the primary lesion. So you should follow-up with the patient SCREENING : mammographic screening Magnetic resonance imaging MRI

Prognosis depends on: 1- Tumor size. (stage) 2- Lymph node involvement (&number of lymph nodes involved) by metastases. 3- Distant metastases. 4- Grade 5- Histologic type (invasive ductal NOS is the worst) 6- Presence or absence of estrogen or progesterone receptors. 7- Proliferative rate of cancer. 8- Aneuploidy (worse prognosis). 9- Overexpression of HER2/NEU (predict response to a monoclonal antibody ("Herceptin")). Most imp.

Male breast pathology Gynecomastia Enlargement of the male breast (not related to cancer unless in pathologic not because of the gynecomastia itself but because of increased estrogen) absolute or relative estrogen excesses. According to cause, divided into: 1- pathologic gynecomastia: important because it indicates that there is a source of excess estrogen: cirrhosis of the liver; Klinefelter syndrome; estrogen-secreting tumors; estrogen therapy (for prostate cancer); digitalis (digoxin) therapy. 2- Physiologic gynecomastia:at both extreme of ages puberty and extreme old age. Under microscopy: exaggeration of normal tissue Enlargement is caused by increased mamillary tissue (lobules)

Carcinoma of the male breast male: female breast cancer 1: 125. advanced age. Because of scant amount of breast substance in male, the tumor rapidly infiltrates overlying skin and underlying thoracic wall. Unfortunately, (½) have lymph nodes mets and more distant sites by time of diagnosis. Rapid advancement